Risk factors for mortality associated with enterococcal bloodstream infections

Infection Control and Hospital Epidemiology

Volumn 17, Issue 9, 1996, Pages 576-580

  Stroud, Leonardo ^a,b   Edwards, Jonathan ^a   Danzig, Lisa ^a   Culver, David ^a   Gaynes, Robert ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; COHORT ANALYSIS; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS INFECTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STREPTOCOCCAL INFECTIONS; UNITED STATES; VANCOMYCIN;

EID: 0030227334     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141943     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 1993;42:596-598.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
3. Korten V. The nosocomial transmission of enterococci. Curr Opin Infect Dis 1993;6:498-505.
4. Graninger W. Nosocomial bacteremia due to E faecalis without endocarditis. Clin Infect Dis 1992;15:49-57.
5. Zervos MJ, Kauffman CA, Therasse PM, et al. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1989;110:515-520.
6. Handwerger S, Raucher B, Altarac D. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
7. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-116.
8. Leclercq R Resistance of enterococci to aminoglycosides and gtycopeptides. Clin Infect Dis 1992;15:495-501.
9. Patterson J. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990;12:644-652.
10. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging problem. Clin Microbiol Rev 1990;3:280-291.
11. Kaye D. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med 1982;142:2006-2009.
12. Horvitz RA, von Graevenitz A. A clinical study of the role of enterococci as sole agents of wound and tissue infection. Yale J Biol Med 1977;50:391-395.
13. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-383.
17. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance 1984. MMWR 1986;35:17S-29S.
18. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infection Surveillance System (NNIS): description of surveillance methodology. Am J Infect Control 1991;19:19-35.
19. SAS Institute Inc. SAS/STAT User's Guide. Version 6, 4th ed, Vol II. Cary, NC: SAS Institute Inc; 1989.
20. Shlaes DM, Levy J, Wolinsky E. Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578-581.
21. Dougherty SH, Flohr AB, Simmons RL 'Breakthrough' enterococcal septicemia in surgical patients: 19 cases and a review of the literature. Arch Surg 1983;118:232-238.
22. Craven DE, Kunches LM, Lichtenburg PA, et al. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988;148:1161-1168.
23. Knaus WA, Wagner DP, Draper EA. Relationships between acute physiologic derangement and risk of death. J Chron Dis 1985;38:295-300.
24. Wagner DP, Knaus WA, Draper EA. Physiologic abnormalities and outcomes from acute disease: evidence for a predictable relationship. Arch Intern Med 1986;146:1389-1396.
25. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991;13:600-605.
26. Dubois RW, Book RH, Rogers WH. Adjusted hospital death rates: a potential screen for quality of medical care. Am J Public Health 1987;77:1162-1167.
27. Knaus WA, Nash DB. Predicting and evaluating patient outcomes. Ann Intern Med 1988;109:521-522.
28. Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet 1985;160:557-561.
29. Maki DG, Agger W. Enterococcal bacteremia: clinical features, the risk of endocarditis and management. Medicine 1988;67:248-269.
30. Gullberg RM, Homann SR Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989;11:74-85.